Investor Overview

Press Releases

Date	Title and Summary	View
1/18/17	Orthofix Announces Resolution of SEC Investigations	Additional Formats
1/10/17	Orthofix Announces Preliminary 2016 Fourth Quarter and Full Year Net Sales Results	Additional Formats
1/9/17	Orthofix Receives FDA and CE Mark Approvals for New Bone Growth Stimulators	Additional Formats
12/20/16	Orthofix to Present at J.P. Morgan Healthcare Conference	Additional Formats
12/13/16	Orthofix Announces Appointment of Alex Lukianov to Board of Directors	Additional Formats
11/17/16	Orthofix to Present at Piper Jaffray Healthcare Conference	Additional Formats
10/31/16	Orthofix International Reports Third Quarter 2016 Financial Results	Additional Formats
10/24/16	Orthofix Announces NASS Coverage Policy Recommendations for Electrical Bone Growth Stimulators	Additional Formats
10/21/16	Orthofix International Schedules Third Quarter 2016 Earnings Release and Conference Call for October 31, 2016	Additional Formats
9/12/16	Orthofix Announces First Patient Enrollment in Osteoarthritis of the Knee Study	Additional Formats

Investor Overview